New method for toxicological assessment of perfluoro mixtures Perfluoro (PFAS) is a group of substances that contains PFOS, PFOA and GenX. Perfluoro substances often occur as pollution in ground water and drinking water.
New Director-General Hans Brug starts at RIVM After the approval of his nomination on the proposal of Minister Ollongren of the Interior and Kingdom Relations on June 1 of this year, Professor J.
Large increase in legionellosis in the Netherlands The Municipal Public Health Services (GGD) received 561 reports of legionellosis over the past year. Never before has RIVM registered as many reports of this disease as in the past year.
Meningococcal type W most notable infectious disease in 2017 The report ‘State of Infectious Diseases in the Netherlands in 2017’ published by RIVM today, provides an overview of the most important developments in infectious diseases in the Netherlands and a
Rapid developments in modern biotechnology are a challenge for risk assessment Due to developments in modern biotechnology, such as genome editing, synthetic biology and regulation of gene expression, many new applications are expected in the next ten years.
Bacteriophages: insufficient understanding of phage treatment of human infections Bacteriophages are viruses that can kill bacteria. The question is whether bacteriophages can be used to treat infections in humans.
National Action Plan for sexual health The Dutch National Action Plan for STI, HIV and sexual health describes the most important goals for the next five years.
Greenhouse gas emissions slightly down in 2017 Despite the growth of the economy, greenhouse gas emissions in the Netherlands in 2017 were1 percent lower than in the previous year.
Addictive nicotine and harmful substances also present in heated tobacco Heated tobacco products are newly available on the market. An example of such a product is the heatstick which is heated with an iQOS, a device that looks like an e-cigarette.
Continued high effectiveness of vaccines against Hib disease A recent study by RIVM and AMC shows that the effectiveness of vaccination against Hib is still high.